Scandion Oncology (SCOL)

Scandion is a biotechnology company. The company develops pharmaceuticals for the treatment of cancer containing drug-resistant cell clones. The leading product of the company, SCO-101, has shown to improve the effect of certain standard cancer treatments during preclinical studies. The head office of the company is located in Copenhagen.

Quotes for Scandion Oncology

Right Now

+/-: 1.9
%: 10,44%
Latest: 20.1
High: 20.9
Low: 17.85
Volume: 690 621
Turnover (SEK): 13 496 050
Value (MSEK): 645,9

Board

CEO

Bo Rode Hansen

Chairman Of The Board

Peter Høngaard

Board

Annie Rasmussen
Bo Hansen
Carl Borrebäck
Christian Vinding Thomsen
Jørgen Bardenfleth
Thomas Feldthus

Articles of association

News

2021-01-19 16:53:53 Spotlight: Market Notice 11/21 - Scandion Oncology A/S will be delisted after close of the market on February 2, 2021
2021-01-19 15:34:24 Scandion Oncology approved for listing on Nasdaq First North Growth Market Sweden on 3 February 2021
2021-01-07 08:53:33 Spotlight: Market Notice 5/21– Last day of trading in Scandion Oncology A/S’s BTA
2021-01-06 16:11:48 Scandion Oncology’s rights issue registered with the Danish Business Authority – BTAs are converted to shares
2020-12-18 17:17:41 Letter from the CEO: Great progress in 2020 - we are ready for 2021!

News agencies

2021-01-19 15:39:20 Finwire: Scandion Oncology byter marknadsplats till First North den 3 februari
2021-01-19 15:34:34 Ritzau: Scandion Oncology approved for listing on Nasdaq First North Growth Market Sweden on 3 February 2021
2021-01-06 16:11:57 Ritzau: Scandion Oncology's rights issue registered with the Danish Business Authority - BTAs are converted to shares
2020-12-28 10:54:45 Finwire: Scandion Oncologys forskningschef har köpt 10 000 aktier
2020-12-18 17:18:02 Ritzau: Letter from the CEO: Great progress in 2020 - we are ready for 2021!

Analysis

2018-10-09 SvD Börsplus: Svår att motstå?

Videos

Largest Owners

Name	Capital %	Votes %	Date
Avanza Pension	5,71	5,71	2020-03-31

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

2021-02-18 Bokslutskommuniké 2020
2021-05-20 Delårsrapport 2021-Q1
2021-05-26 Årsstämma 2020
2021-08-19 Delårsrapport 2021-Q2
2021-11-18 Delårsrapport 2021-Q3
2022-02-16 Bokslutskommuniké 2021

Scandion Oncology

Quotes for Scandion Oncology

Right Now

Board

News

News agencies

Analysis

Videos

Presentation av Scandion Oncology A/S med CEO Bo Rode Hansen hos Nordnet Danmark (EN).

Scandion Oncology’s CEO comments on ongoing rights issue

Company Presentation

Largest Owners

Insider trading

Key Numbers

Upcoming reports

Annual reports, prospectus etc.

Technical analysis

SCOL- 2019-03-07

Technical analysis

SCOL- 2019-01-07